Predictive Oncology (POAI) Competitors $1.45 -0.02 (-1.36%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.46 +0.01 (+0.34%) As of 02/21/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends POAI vs. NMTC, DXR, XAIR, POCI, PYPD, COCH, WOK, SURG, DHAI, and IRIXShould you be buying Predictive Oncology stock or one of its competitors? The main competitors of Predictive Oncology include NeuroOne Medical Technologies (NMTC), Daxor (DXR), Beyond Air (XAIR), Precision Optics (POCI), PolyPid (PYPD), Envoy Medical (COCH), WORK Medical Technology Group LTD Ordinary Shares (WOK), SurgePays (SURG), DIH Holding US (DHAI), and IRIDEX (IRIX). These companies are all part of the "medical equipment" industry. Predictive Oncology vs. NeuroOne Medical Technologies Daxor Beyond Air Precision Optics PolyPid Envoy Medical WORK Medical Technology Group LTD Ordinary Shares SurgePays DIH Holding US IRIDEX NeuroOne Medical Technologies (NASDAQ:NMTC) and Predictive Oncology (NASDAQ:POAI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, community ranking, analyst recommendations, institutional ownership, media sentiment and dividends. Does the media refer more to NMTC or POAI? In the previous week, Predictive Oncology had 8 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 8 mentions for Predictive Oncology and 0 mentions for NeuroOne Medical Technologies. Predictive Oncology's average media sentiment score of 0.60 beat NeuroOne Medical Technologies' score of 0.00 indicating that Predictive Oncology is being referred to more favorably in the news media. Company Overall Sentiment NeuroOne Medical Technologies Neutral Predictive Oncology Positive Which has preferable valuation and earnings, NMTC or POAI? NeuroOne Medical Technologies has higher revenue and earnings than Predictive Oncology. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Predictive Oncology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuroOne Medical Technologies$3.45M10.33-$12.32M-$0.26-4.44Predictive Oncology$1.78M5.45-$13.98M-$3.05-0.48 Do insiders & institutionals believe in NMTC or POAI? 16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. Comparatively, 9.0% of Predictive Oncology shares are owned by institutional investors. 8.9% of NeuroOne Medical Technologies shares are owned by company insiders. Comparatively, 3.4% of Predictive Oncology shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is NMTC or POAI more profitable? NeuroOne Medical Technologies has a net margin of -82.17% compared to Predictive Oncology's net margin of -1,012.32%. NeuroOne Medical Technologies' return on equity of -270.70% beat Predictive Oncology's return on equity.Company Net Margins Return on Equity Return on Assets NeuroOne Medical Technologies-82.17% -270.70% -129.70% Predictive Oncology -1,012.32%-286.30%-122.11% Which has more risk & volatility, NMTC or POAI? NeuroOne Medical Technologies has a beta of 0.48, meaning that its share price is 52% less volatile than the S&P 500. Comparatively, Predictive Oncology has a beta of 1.25, meaning that its share price is 25% more volatile than the S&P 500. Do analysts rate NMTC or POAI? Predictive Oncology has a consensus target price of $3.00, suggesting a potential upside of 106.19%. Given Predictive Oncology's stronger consensus rating and higher possible upside, analysts plainly believe Predictive Oncology is more favorable than NeuroOne Medical Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NeuroOne Medical Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Predictive Oncology 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the MarketBeat Community believe in NMTC or POAI? Predictive Oncology received 86 more outperform votes than NeuroOne Medical Technologies when rated by MarketBeat users. However, 71.59% of users gave NeuroOne Medical Technologies an outperform vote while only 64.22% of users gave Predictive Oncology an outperform vote. CompanyUnderperformOutperformNeuroOne Medical TechnologiesOutperform Votes6371.59% Underperform Votes2528.41% Predictive OncologyOutperform Votes14964.22% Underperform Votes8335.78% SummaryNeuroOne Medical Technologies beats Predictive Oncology on 9 of the 17 factors compared between the two stocks. Get Predictive Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for POAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart POAI vs. The Competition Export to ExcelMetricPredictive OncologySurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.77M$10.18B$5.80B$8.94BDividend YieldN/A1.38%4.78%3.85%P/E Ratio-0.4818.2426.4118.84Price / Sales5.4542.45450.1476.68Price / CashN/A19.4144.0437.47Price / Book0.715.407.634.64Net Income-$13.98M$284.66M$3.18B$245.69M7 Day Performance-10.19%-4.30%-1.82%-2.59%1 Month Performance14.57%-2.93%0.22%-2.30%1 Year Performance-60.89%-13.09%17.25%13.71% Predictive Oncology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)POAIPredictive Oncology1.8926 of 5 stars$1.45-1.4%$3.00+106.9%-61.0%$9.67M$1.78M-0.4830NMTCNeuroOne Medical Technologies0.119 of 5 stars$1.20+12.1%N/A+3.6%$37.03M$3.45M-2.6120DXRDaxor3.4327 of 5 stars$7.19-3.6%$24.75+244.2%-9.5%$34.80MN/A0.0037XAIRBeyond Air4.6625 of 5 stars$0.44+5.4%$3.67+737.7%-81.0%$33.28M$1.16M-0.3170High Trading VolumePOCIPrecision Optics0.3316 of 5 stars$4.99-3.1%N/A-26.8%$31.69M$19.10M-8.0580News CoverageGap DownPYPDPolyPid2.3356 of 5 stars$3.07+0.3%$11.33+269.2%-44.0%$31.28MN/A-0.3980Gap UpCOCHEnvoy Medical2.7718 of 5 stars$1.54flat$8.00+419.5%+13.8%$31.19M$320,000.000.0034Gap UpWOKWORK Medical Technology Group LTD Ordinary SharesN/A$2.08-2.8%N/AN/A$30.16MN/A0.00226Lockup ExpirationGap DownSURGSurgePays2.8477 of 5 stars$1.46+2.8%$8.50+482.2%-80.7%$29.43M$137.14M-1.2940High Trading VolumeDHAIDIH Holding US0.4216 of 5 stars$0.69+3.5%N/A-59.4%$27.93M$64.47M0.00N/AEarnings ReportGap DownIRIXIRIDEX0.9636 of 5 stars$1.61flat$2.00+24.2%-38.6%$26.79M$51.87M-2.40120Analyst ForecastNews Coverage Related Companies and Tools Related Companies NeuroOne Medical Technologies Competitors Daxor Competitors Beyond Air Competitors Precision Optics Competitors PolyPid Competitors Envoy Medical Competitors WORK Medical Technology Group LTD Ordinary Shares Competitors SurgePays Competitors DIH Holding US Competitors IRIDEX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:POAI) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Predictive Oncology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Predictive Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free POAI Stock Alerts